companydata.dkcompanydata.dk

NORMEDI DANMARK ApS: Financial statements 2019

CVR: 35663290

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

NORMEDI DANMARK ApS (CVR 35663290) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,724,951 and a net result of DKK 624,494 compared with DKK 92,558 the year before. That is an increase of 133.6% compared with the year before. Equity in the 2019 report amounted to DKK 677,109. The solvency ratio was 34.6%. The company had 1 employee in the financial year.

Gross Profit
DKK 1,724,951
Profit/Loss
DKK 624,494
Equity
DKK 677,109
Total Assets
DKK 1,959,412
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-1.7M624K677K1
2018-738K93K93K1
2017-789K-32K561
2016-850K131K32K1
2015--00-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

NORMEDI DANMARK ApS: The 2018 annual report is outMar 21, 2019

NORMEDI DANMARK ApS has published its annual report for 2018. Gross profit came to DKK 738,354, and the net result was DKK 92,558.

About NORMEDI DANMARK ApS

NORMEDI DANMARK ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2014. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named ApS STAKE NR. 5035. The management consists of Jesper Steffensen. The board consists of Michelangelo Stefani (chair), Jesper Steffensen and Joao Malagueira. The company is owned by Hologic GGO 4 Ltd. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 1,460,197 and a net result of DKK 386,079 compared with DKK -74,099 the year before. Equity in the 2025 report amounted to DKK 1,852,127.

Source: annual report 2025, Danish Business Authority